AP026 (TQA2226)

· Chia Tai Tianqing Pharmaceutical Group; Nanjing Shunxin Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AP026 (TQA2226), covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects. [Phase 1]